1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmacy Benefit Manager (PBM) Market in the US 2015-2019

Pharmacy Benefit Manager (PBM) Market in the US 2015-2019

  • December 2015
  • -
  • Infiniti Research Limited
  • -
  • 69 pages

About PBMs
PBMs are responsible for processing prescriptions for corporations or insurance companies. Earlier, their major role was administration and negotiation with drug pharmacies and manufacturers to get rebates on drug prices. Now they have evolved into entities taking over the drug benefit portion of health plans in the US. Recent healthcare reforms in the US have contributed significantly to increase their area of expertise. Increase in costs of drugs and other healthcare services has made PBM's services more desirable. PBMs act as an intermediary between the payer and other entities in a healthcare system. They generate revenue through service fees they charge from large customer contracts for activities such as operating mail-order pharmacies, processing prescriptions, and negotiating with drug manufacturers and pharmacies.
Technavio's analysts forecast the PBM market in the US to grow at a CAGR of 7.16% during 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the PBM market in the US for the period of 2015-2019. To calculate the market size, the report considers revenue generated by PBMs by offering pharmacy benefit services to end-users in the healthcare market in the US.
Technavio's report, Pharmacy Benefit Manager (PBM) Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the PBM market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors
- Catamaran
- CVS Health (CVS Caremark)
- Express Scripts
- OptumRx
- Prime Therapeutics
Other prominent vendors

- Aetna
- Argus Health Systems
- Centene
- Cigna
- Humana
- Medlmpact
- Rite Aid
Market driver
- Increase in healthcare expenditure
- For a full, detailed list, view our report
Market challenge
- Criticisms of PBMs
- For a full, detailed list, view our report
Market trend
- Shift toward multi-tier prescription drug plans by employers
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Pharmacy Benefit Manager (PBM) Market in the US 2015-2019
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: US: Economic profile
PART 06: Global pharmaceuticals market
- Global pharmaceuticals market
- US pharmaceuticals market
PART 07: PBM: An overview
PART 08: PBM market in US
- Market overview
- Market size and forecast
- PBM market in US by Medicare members
- PBM market in US by managed Medicaid members
- Five forces analysis
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
- Competitive scenario
- Market share analysis 2014
- Other prominent vendors
PART 15: Key vendor analysis
- Catamaran
- CVS Health
- Express Scripts
- OptumRx
- Prime Therapeutics
PART 16: Other prominent vendors
- Aetna
- Argus Health Systems
- Centene
- Cigna
- Humana
- MedImpact
- Rite Aid
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio
LOE
Exhibit 01: Product offerings
Exhibit 02: US GDP 2009-2014 ($ trillions)
Exhibit 03: US GDP per capita 2009-2014 ($ thousands)
Exhibit 04: US population 2009-2014 (millions)
Exhibit 05: US population by age group 2014
Exhibit 06: Global pharmaceuticals market 2014-2019 ($ trillions)
Exhibit 07: Global pharmaceuticals market by geography 2014
Exhibit 08: Pharmaceuticals market in US 2006-2013 ($ billions)
Exhibit 09: Pharmaceuticals market in US 2014-2019 ($ billions)
Exhibit 10: US drug approvals: Specialty versus traditional drugs 2006-2014
Exhibit 11: US prescription drug spending 2014-2019 ($ billions)
Exhibit 12: Per capita pharmaceutical spending: US versus other countries 2014 and 2019 ($)
Exhibit 13: PBMs: Areas of expertise
Exhibit 14: Key activities of PBMs
Exhibit 15: PBM market in US 2014-2019 ($ billions)
Exhibit 16: Growth of insurance in US 2014-2019 (millions of lives)
Exhibit 17: Growth in PBM-managed lives in US 2012-2019 (millions of lives)
Exhibit 18: PBM-managed lives under Medicare 2014-2019 (millions of lives)
Exhibit 19: Medicare members in US by PBM 2014
Exhibit 20: PBM-managed lives under managed Medicaid program 2014-2019 (millions of lives)
Exhibit 21: Managed Medicaid members in US by PBM 2014
Exhibit 22: Five forces analysis
Exhibit 23: Aging population in US 2010-2050
Exhibit 24: Decrease in mortality rate in US 2011-2012 (deaths per 100,000 in standard population)
Exhibit 25: Impact of drivers
Exhibit 26: Rise of private exchange contribution plans in US: 2010 versus 2014 (millions of lives)
Exhibit 27: US states with PBM regulations 2013
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Specialty drugs market in US 2014-2019 ($ billions)
Exhibit 30: MandA in PBM market in US
Exhibit 31: PBM market in US: Vendor segmentation by revenue 2014
Exhibit 32: PBM market in US: Vendor segmentation by equivalent prescription 2014
Exhibit 33: PBM market in US: Vendor segmentation by PBM lives 2014
Exhibit 34: Business segmentation of Catamaran
Exhibit 35: Catamaran: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Catamaran: Geographical segmentation by revenue 2014
Exhibit 37: CVS Health: Business segmentation by revenue 2014
Exhibit 38: Express Scripts: Business segmentation by revenue 2014
Exhibit 39: Express Scripts: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 40: OptumRx: Service segmentation
Exhibit 41: Prime Therapeutics: Business segmentation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.